Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01194674 · ClinicalTrials.gov registry record · Phase 1
Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema
A Phase 1 study, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01194674 is a Phase 1 study that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 2 participants.
The verdict
NCT01194674, a Phase 1 study, was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the safety and efficacy of microplasmin as a treatment for uveitic macular edema.
Interventions
- DRUG Microplasmin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01194674
The ClinicalTrials.gov registry entry for NCT01194674 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Microplasmin is the first listed.
NCT01194674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01194674 about?
NCT01194674 is a clinical study titled "Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema". The objective of this study is to investigate the safety and efficacy of microplasmin as a treatment for uveitic macular edema.
What is the current status of trial NCT01194674?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2011-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01194674?
The interventions under investigation include: Microplasmin (DRUG).
Who is sponsoring clinical trial NCT01194674?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.